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Background. Panic disorder with agoraphobia is characterized by panic attacks and anxiety in situations where escape
might be difficult. However, neuroimaging studies specifically focusing on agoraphobia are rare. Here we used
functional magnetic resonance imaging (fMRI) with disorder-specific stimuli to investigate the neural substrates of
agoraphobia.
Method. We compared the neural activations of 72 patients suffering from panic disorder with agoraphobia with
72 matched healthy control subjects in a 3-T fMRI study. To isolate agoraphobia-specific alterations we tested the effects
of the anticipation and perception of an agoraphobia-specific stimulus set. During fMRI, 48 agoraphobia-specific and
48 neutral pictures were randomly presented with and without anticipatory stimulus indicating the content of the
subsequent pictures (Westphal paradigm).
Results. During the anticipation of agoraphobia-specific pictures, stronger activations were found in the bilateral ventral
striatum and left insula in patients compared with controls. There were no group differences during the perception phase
of agoraphobia-specific pictures.
Conclusions. This study revealed stronger region-specific activations in patients suffering from panic disorder with
agoraphobia in anticipation of agoraphobia-specific stimuli. Patients seem to process these stimuli more intensively
based on individual salience. Hyperactivation of the ventral striatum and insula when anticipating agoraphobia-
specific situations might be a central neurofunctional correlate of agoraphobia. Knowledge about the neural correlates
of anticipatory and perceptual processes regarding agoraphobic situations will help to optimize and evaluate treatments,
such as exposure therapy, in patients with panic disorder and agoraphobia.
Received 6 June 2013; Revised 20 November 2013; Accepted 28 November 2013; First published online 7 January 2014
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Introduction
Agoraphobia is characterized as a phobic anxiety in
situations where escape can be difficult or embarrass-
ing. Examples of these situations include wide-open
spaces, crowded places, shopping malls and public
transportation. Patients often anticipate panic attacks
or panic-like symptoms, such as a pounding heart or
accelerated heart rate, sweating, a feeling of choking,
chest pain, dizziness and a fear of dying. Panic dis-
order and agoraphobia, with a 12-month prevalence
of 1.8% and 2%, belong to the most prevalent group
of mental disorders – anxiety disorders (Wittchen et al.
2011). More than a third of patients with panic dis-
order also suffer from agoraphobia (Kessler et al. 2006).
The neural processing of aversive and anxiety-
related stimuli relies on the so-called ‘fear network’
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(Gorman et al. 2000). As core regions, the amygdala,
hippocampus (Sakai et al. 2005; van den Heuvel et al.
2005) and insula (Nagai et al. 2007; Wittmann et al.
2011) show increased activation in patients with panic
disorder with and without agoraphobia. Unfortu-
nately, most previous studies lack information con-
cerning the coincidence of agoraphobia and therefore
insights into neural networks specific to agoraphobia
are limited (Dresler et al. 2012). Arguably, the neural
response of individuals suffering from panic disorder
with agoraphobia to the anticipation of, and the con-
frontation with, agoraphobic situations is equivalent
to in vivo exposure. Since in vivo exposure is a first-
choice psychotherapeutical intervention for panic dis-
order with agoraphobia (Gloster et al. 2011), measuring
these neural reactions is a highly relevant task. In ad-
dition to this, despite the fact that anticipatory anxiety
often impairs the daily life of patients to a much
greater extent than the anxiety in an agoraphobic situ-
ation itself, the anticipatory processes of agoraphobia-
related stimuli have not been the focus of large-scale
neuroimaging studies. In consequence, the specifically
altered activity of the different areas participating in
neural processes associated with anticipation and per-
ception of aversive and agoraphobia-related stimuli
has not been identified.
Studies investigating the anticipation of aversive
and anxiety-related stimuli have found an increased
activation in the amygdala, anterior cingulate cortex
(Ueda et al. 2003) and the insula (Simmons et al. 2006;
Wittmann et al. 2011) as core regions of the neural
fear network. (For a more detailed overview of symp-
tom provocation in anxiety disorders, please refer
to Wittmann et al. 2011.) The ventral striatum (VS)
was found to be crucial during the anticipation and
identification of stimuli with emotional significance
(Phillips et al. 2003; Lorberbaum et al. 2004; Herwig
et al. 2007). Recent studies have shown the mediating
role of the VS in anticipatory processes of both appeti-
tive and aversive stimuli in healthy volunteers (Liu
et al. 2011; Yang et al. 2012) and anxiety disorders
(Guyer et al. 2012).
Therefore, we developed an agoraphobia-specific
stimuli set and established a functional magnetic
resonance imaging (fMRI) paradigm including an
anticipation phase. In honour of Carl Westphal,
who first described agoraphobia as a distinct dis-
order (Westphal, 1871), we named this paradigm the
‘Westphal paradigm’ (Wittmann et al. 2011). A pilot
study revealed neurofunctional activations in patients
suffering from panic disorder with agoraphobia,
including amygdala, insula and parahippocampal
areas. The paradigm also produces reliable self-report
data and its psychometric properties meet the necess-
ary quality requirements with regard to criterion and
construct validity as well as reliability (Wittmann
et al. 2011). These aspects indicate that the Westphal
paradigm can be used to further characterize the
neurofunctional basis of panic disorder with agora-
phobia. In the present study we report the comparison
of a large group of patients, matched with healthy
participants, to demonstrate disorder-specific neural
processes related to the anticipation and perception
of agoraphobia-specific stimuli.
We hypothesized that patients who suffer from
panic disorder with agoraphobia would show altered
neural processes when anticipating and perceiving
agoraphobia-specific stimuli compared with matched
healthy controls. While we expected larger blood
oxygen level dependence (BOLD) responses in areas
of the fear network including the amygdala and insula
(Sakai et al. 2005; van den Heuvel et al. 2005; Nagai
et al. 2007; Holzschneider & Mulert, 2011; Wittmann
et al. 2011) during both the anticipation and perception
of agoraphobia-specific stimuli, we hypothesized
heightened activation during the anticipation of
agoraphobia-specific stimuli in the VS (Jensen et al.
2003; Herwig et al. 2007; Schiller et al. 2008).
Method
Participants
Volunteers were recruited from the participating
universities and fMRI centres in Aachen, Berlin-
Charité, Berlin-Adlershof, Dresden and Münster. All
patients took part in the German multicentre trial,
‘Mechanisms of Action in CBT’ (MAC) (Gloster et al.
2009), and therefore met the diagnostic criteria for
panic disorder with agoraphobia (Diagnostic and
Statistical Manual of Mental Disorders, fourth edition,
text revision; DSM-IV-TR) as determined by a stan-
dardized computer-administered personal Composite
International Diagnostic Interview (CAPI-WHO-CIDI;
DIA-X-CIDI version; Wittchen & Pfister, 1997) conduc-
ted by trained professionals. No patients with isolated
panic disorder, isolated agoraphobia, or panic attacks
were included in the study. Additionally, all patients
had a score 518 on the structured interview guide
for the Hamilton Anxiety Scale (HAMA; Shear et al.
2001) and a score 54 on the Clinical Global Im-
pressions Scale (Guy, 1976). Patients were aged be-
tween 18 and 65 years old and had not received
psychopharmacological treatment for at least 4 weeks
before the beginning of the study, nor had they taken
part in any psychotherapeutic treatment. Other ex-
clusion criteria were co-morbid psychotic or bipolar I
disorder, current alcohol dependence/current abuse
of or dependence on psychoactive substances, current
suicidal ideations, borderline personality disorder,
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significant abnormalities in electroencephalography
(EEG), electrocardiology (ECG), routine clinical chem-
istry or haematology. Handedness was measured by
the Edinburgh Inventory (Oldfield, 1971). Colour
vision was assessed with the Ishihara colour blindness
test (Ishihara, 1917). Healthy controls had to pass the
same diagnostic procedure; had to have never fulfilled
criteria for a mental disorder; and were individually
matched for age, gender, handedness, smoking status
and education level of the included patients. All
participants additionally did not meet the MRI con-
traindications (e.g. ferromagnetic material or cardiac
pacemakers). The diagnostic procedure was accom-
plished within a maximum of 7 days prior to the
scan. The age of the patients and healthy controls did
not differ (p=0.825), values of the HAMA (Shear
et al. 2001) differed significantly (p<0.001); however,
values for the Mobility Inventory (MI; Chambless
et al. 1985) were not available for healthy volunteers
(see Table 1). All participants were asked to refrain
from smoking for at least 4 h prior to the scan. Out
of 369 patients who met these criteria, a total of 89
patients underwent fMRI before any therapeutic inter-
vention took place. Therefore anxiety regarding the
scanner environment was relatively high in most
patients. An empathic step-by-step explanation of the
procedure and therefore enabling a maximum of con-
trol helped them to cope with this aversive experience.
However, five patients refused to participate in the
fMRI session because their anxiety levels were
too high. Scans of 12 patients were discarded due
to excessive head movements of more than twice the
voxel size (n=4) or due to the joint multicentre
criteria of data quality (n=8). For the latter joint quality
control (Kircher et al. 2013) a percent signal fluctuation
index (PSF; Stocker et al. 2005) and a signal-to-
fluctuation noise ratio (SFNR; Friedman & Glover,
2006) were calculated. The threshold for data exclusion
was a value greater than 2.5 s.D.s on the PSF and
SFNR. For the control group we included 72 matched
healthy volunteers who were separately recruited ac-
cording to the matching criteria of each already
recruited patient. All participants gave their written
informed consent. The clinical trial was approved
by the Ethics Committee of the Medical Faculty of
the Technische Universität Dresden (EK 164082006).
The neuroimaging study was approved by the
ethics committees of all participating sites. All
approvals were made according to the Declaration of
Helsinki.
Experimental design
We used the Westphal paradigm (as shown in Fig. 1),
which had already been evaluated in a pilot study
(Wittmann et al. 2011). It is composed of 48
agoraphobia-related pictures specifically generated
for this paradigm (e.g. pictures of means of public
transportation, images of crowds, heights, auto-
mobiles, dense situations, etc.). Pictures were taken
according to the examples of agoraphobic situations
from the DSM-IV as well as from the interviews with
patients (with panic disorder and agoraphobia). After
being selected by experts, the remaining pictures
were rated by patients and matched healthy controls
using the Self-Assessment Manikin Scale (Bradley &
Lang, 1994). Only pictures with rating values which al-
lowed us to discriminate between patients and controls
were included in the paradigm (Wittmann et al. 2011).
Furthermore, 48 neutral pictures were taken from the
International Affective Picture System (Lang et al.
1997). Half of the 96 pictures were preceded by an an-
ticipatory stimulus that indicated the category of the
upcoming picture using the words ‘neutral’ and
‘panic’. The other half of the set of pictures was pre-
ceded by a non-specific anticipation stimulus, i.e. a
random combination of characters (‘DGHNTFJ’).
Thus, 24 pictures were presented in each condition.
The picture sequence was randomized for each partici-
pant. Presentation duration for each picture was 2000
ms and 250ms for anticipatory stimuli. Both were
separated by the presentation of a fixation cross in
order to minimize artifacts due to eye movements
with a variable duration of between 2 and 4 s.
Inter-trial intervals were variable with a duration of be-
tween 2 and 6 s. The complete experiment duration
Table 1. Sociodemographic and clinical data of subjects included in
the study (47 women and 25 men)
Patients with
panic disorder
with agoraphobia
Healthy
controls
n 72 72
Mean age, years (S.D.)a 36.7 (11.2) 36.2 (11.2)
Left-handed, n 10 10
Smoking, n 31 31
Education, n
13 years 31 31
10 years 33 33
9 to 10 years 8 8
Mean HAMA (S.D.) 23.1 (6.3)* 2.0 (2.3)
Mean MI (S.D.) 2.8 (0.8) –
S.D., Standard deviation; HAMA, Hamilton Anxiety Scale;
MI, Mobility Inventory.
a Age of patients and healthy controls did not differ
(p=0.825).
* Mean value was significantly different from that of the
control group (p<0.001).
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was approximately 15min. Presentation version 11.0
(Neurobehavioral Systems, USA) was used to present
the stimuli. During the fMRI session participants
were instructed to pay attention to the picture content.
They were requested to try to experience the presented
situation and to imagine being in it at that moment.
Furthermore, they were asked to pay attention to the
anticipatory stimulus and its predictive content before
picture presentation. Attention to the paradigm and its
pictures was assured by the request to push a button
each time a picture was presented.
Self-report data
In order to estimate the validity of the agoraphobia-
specific and neutral pictures all stimuli were rated
in terms of agoraphobic anxiety, arousal and valence
after the scanning session on a modified Self-
Assessment Manikin Scale (Bradley & Lang, 1994).
Ratings were analysed using a 2×2 analysis of variance
for repeated measures [group (patients/controls)×pic-
ture type (agoraphobia/neutral)] with group as the
between-subject factor and picture type as the within-
subject factor. Post-hoc t tests were used to determine
group differences. Associations between anxiety rat-
ings and clinical data were achieved by calculating
Pearson’s correlations.
Functional imaging
Assurance of data quality was in line with the pro-
cedure within the joint multicentre quality control
(Kircher et al. 2013). Functional imaging was per-
formed on 3-T General Electric Healthcare (Berlin),
3-T Siemens Trio (Dresden) and 3-T Philips Achieva
(Münster and Aachen) scanners. During each fMRI ses-
sion, 446 volumes were acquired using the following
parameters to minimize artifacts and signal loss:
echo planar imaging (EPI) pulse sequence; echo time
=30ms; repetition time=2 s; flip angle=90°; matrix
(a)
(b)
Anxiety rating [mean (S.D.)]
Fig. 1. (a) Anxiety ratings of patients ( ) and healthy controls ( ) for agoraphobia-specific and neutral pictures. Data are
given as means with standard deviations represented by vertical bars. (b) Design of the Westphal paradigm, illustrated by
examples for the four different kinds of trials (expected and unexpected agoraphobia-specific and neutral pictures) and their
sequenced presentation in the course of time.
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size=64×64; voxel size=3.6×3.6×3.8 mm; 30 slices
without an intersection gap were collected, aligned
parallel to the anterior commissure–posterior com-
missure (AC-PC) line, interleaved and in ascending
order. Data analysis was carried out using Statistical
Parametric Mapping (version SPM8, http://www.
fil.ion.ucl.ac.uk/spm). Preprocessing consisted of cor-
recting slice-time acquisition delay and movement
(by realigning to the individual mean EPI), spatial nor-
malization to the standard EPI template and spatial
smoothing with 8mm full width at half-maximum.
The first five volumes of each time series were dis-
carded to avoid non-steady-state effects caused by T1
saturation. The BOLD response was analysed in the
context of the general linear model using a two-level
approach.
On the first level (the single-subject level) the three
anticipatory stimuli (‘panic’, ‘neutral’ and, in the un-
expected condition, ‘DGHNTFJ’) and the picture
onsets constitute four different trial types: (1) ‘expec-
ted agoraphobia-specific picture’, (2) ‘unexpected
agoraphobia-specific picture’, (3) ‘expected neutral
picture’, (4) ‘unexpected neutral picture’, which were
modelled as explanatory conditions following con-
volution with the haemodynamic response function.
Movement parameters were included as additional
regressors. Contrast images were computed for the
anticipation phase, ‘agoraphobic anticipation minus
neutral anticipation’, and for the picture phase,
‘all agoraphobia-specific pictures minus all neutral pic-
tures’, combining expected and unexpected pictures
[(1+2) – (3+4)] (see Fig. 1). On the second level
(the group level) we computed one-sample and two-
sample t tests with the appropriate contrast images
during the anticipation and during the picture phase
for determining within-group activation and differ-
ences in neural activations between patients and
healthy controls. Study sites were included as ad-
ditional regressors.
Due to strong a priori hypotheses, a correction for
multiple comparisons was carried out using SPM’s
small volume correction (SVC) at p<0.05 family-wise
error (FWE)-corrected. Based on previous findings,
group differences during the anticipation phase were
expected in the a priori-defined volumes of interest
(VOIs) in the VS, insula and amygdala. During the pic-
ture phase we also defined the insula and the amyg-
dala as VOIs. Amygdala and insula VOIs were
generated using the AAL-Atlas (Tzourio-Mazoyer
et al. 2002) within the WFU PickAtlas software toolbox
(Maldjian et al. 2003). The VOI for the VS was defined
using the probabilistic literature-based SPM tool
(Schubert et al. 2008). Results of the whole-brain analy-
sis are reported at p<0.05 FWE whole brain-corrected
with a cluster extension of five voxels.
Associations between ratings of the agoraphobia-
specific pictures, clinical measure of agoraphobic
avoidance behaviour (using the MI; Chambless et al.
1985) as well as neural activation (using mean par-
ameter estimates extracted from the VOIs) were com-
puted using Pearson’s correlations within SPSS (IBM,
USA).
Results
Self-report data
Ratings of agoraphobia-specific and neutral pictures
revealed a significant main effect of group (F1,137=
106.97, p<0.001, ηp
2 =0.438) and picture type (F1,137 =
245.11, p<0.001, ηp
2 =0.641) and a group×picture type
interaction (F1,137=166.98, p<0.001, ηp
2 =0.549). Post-hoc
t tests indicated that patients rated the agoraphobia-
specific pictures more anxiety inducing (t137=12.09,
p<0.001), more unpleasant (t137=6.12, p<0.001) and
more arousing (t137=9.79, p<0.001) than healthy con-
trols, while there were no group differences for the rat-
ings of neutral pictures (all p values>0.011) (see online
Supplementary Table S1).
The relationship between the anxiety ratings of
the agoraphobia-specific pictures and symptom sev-
erity was assessed within the patient group. We
found significant positive correlations between anxiety
ratings and the MI (unaccompanied) score (r=0.47,
p<0.001).
fMRI
Anticipation phase
When the patients were anticipating agoraphobia-
related compared with neutral stimuli, an increased
activation in the bilateral VS and left insula was
observed (left VS: T=2.42, x=−18, y=5, z=−8,
pSVC for VS VOI=0.072; right VS: T=2.7, x=15, y=5,
z=−8, pSVC for VS VOI=0.039; left insula: T=4.57,
x=−39, y=17, z=−8, pSVC for insula VOI=0.003) while
the healthy control group showed no significant acti-
vation or deactivation. There was no activation of the
amygdala during the anticipation of agoraphobia-
specific stimuli.
Comparing the activations of both groups, patients
displayed stronger activation in the bilateral VS (see
Fig. 2) and left insula (left VS: T=3.5, x=−18, y=5,
z=−8, pSVC for VS VOI=0.004; right VS: T=4.0, x=15,
y=8, z=−8, pSVC for VS VOI=0.001; left insula: T=4.2,
x=−30, y=26, z=10, pSVC for insula VOI=0.005). The
hypothesized stronger activation in the amygdala of
patients compared with healthy controls was not
observed. There were neither significant group differ-
ences, nor within-group activations or deactivations
Neural correlates of agoraphobia 2389
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Fig. 2. Activation in the ventral striatum (bilateral) is stronger in patients than in healthy controls when anticipating agoraphobia-specific stimuli and mean parameter estimates
correlate with the values of anxiety ratings of 68 patients for agoraphobia-specific stimuli.
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in the whole-brain analyses (FWE whole brain-
corrected) outside the predefined VOIs.
Extracting mean parameter estimates from the VS
VOI and correlating these values with the anxiety
ratings showed significant positive correlations for
the patient group (right VS: r=0.24, p=0.041; left VS:
r=0.27, p=0.021), as displayed in Fig. 2. Mean para-
meters of the left insula VOI were positively correlated
with the values of the MI (unaccompanied) (r=0.29,
p=0.015).
Picture phase (agoraphobia-specific pictures v. neutral
pictures)
Contrary to our initial hypothesis, there were no
significant group differences when comparing
agoraphobia-specific pictures with neutral pictures in
the a priori-defined areas of the amygdala and insula
(after small volume correction) nor in the whole-brain
analyses (pFWE whole brain corrected p>0.2).
However, the patient group displayed a significant
activation in the bilateral insula (left insula: T=5.3,
x=−30, y=20, z=−20, pSVC for insula VOI<0.001; right
insula: T=4.44, x=33, y=17, z=−20; pSVC for insula VOI=
0.004) while perceiving agoraphobia-specific compared
with neutral stimuli, but no significant group differ-
ence was observed in this region.
In the whole-brain analyses both healthy controls
and patients showed neuronal responses elicited by
agoraphobia-specific compared with neutral pictures
in areas involved in the processing of spatial infor-
mation including parahippocampal areas and occipital
areas as well as areas associated with panic disorder
and agoraphobia such as the posterior cingulum and
precuneus (see Table 2).
Discussion
This is the first study comparing the neural activations
of patients suffering from panic disorder with agora-
phobia and healthy controls to agoraphobia-specific
stimuli. We found an increased activation in the insula
and the VS in patients compared with healthy controls
during the anticipation of agoraphobia-specific stimuli,
while no group differences were found during the per-
ception phase.
From a clinical perspective we know that patients
often report much higher anxiety before entering an
agoraphobic situation compared with being in the situ-
ation itself (Helbig-Lang et al. 2012). Our finding of
higher BOLD responses in the insula and VS only in
anticipation but not in perception of agoraphobia-
related stimuli in patients supports this important dif-
ferentiation between anticipation and event. The insula
has been shown to be involved in the processing of an-
ticipatory anxiety (Boshuisen et al. 2002; Simmons et al.
2006; Herwig et al. 2007) and salience (Menon &
Uddin, 2010). Within this salience network model,
the insula is relevant for (a) the detection of salient
events, (b) switching access to attention and working
memory resources when salient events are detected,
(c) the modulation of autonomic reactivity to the sali-
ent stimuli, and (d) channelling fast access to the
motor system. These functions of the insula might be
even more important in patients with high agorapho-
bic avoidance behaviour, as suggested by the positive
correlation between heightened anticipatory insula ac-
tivation with the MI questionnaire. Arguably, our
results additionally suggest an increased activation
of the insula in patients during their day-to-day life.
Thus, whenever they anticipate being confronted
with an agoraphobic situation, an increased insula
activity may cause increased perception of internal
body symptoms (such as heartbeat, respiration, etc.)
that may be followed by a higher probability of
panic attacks (Delgado et al. 2009). The insula (as a
cortical region relevant for processing interoceptive
signals) would play a crucial role in the neural fear
circuit and in the vicious circle of panic attacks,
respectively.
The VS is known to be relevant for the evaluation of
the individual salience of stimuli while planning beha-
vioural reactions (Horvitz, 2002; Jensen et al. 2003;
Delgado et al. 2009; Heinz & Schlagenhauf, 2010; van
den Heuvel et al. 2011). The increased activation of
the VS may represent pathological processes, such as
exploring the environment for potential threats, evalu-
ating, and preparing actions. Arguably, this mech-
anism is hypersensitive in patients suffering from
anxiety disorders such as agoraphobia (Paulus &
Stein, 2006; Simmons et al. 2006). Moreover, the VS
seems to affect avoidance learning with regard to an
aversive event (Jensen et al. 2003; Schiller et al. 2008;
Delgado et al. 2009) or during the planning of actions
(van den Heuvel et al. 2011), processes that are im-
portant for the development of avoidance behaviour
towards agoraphobic situations. Finally, the finding
of the correlation between anxiety ratings of agora-
phobia-specific stimuli and activation in the bilateral
VS supports the hypothesis that there is a relationship
between dysfunctional VS activation and the clinical
impairment of agoraphobia.
During the perception of agoraphobia-specific
compared with neutral pictures patients and healthy
controls activated areas involved in the processing
of spatial information like the parahippocam-
pal place area and occipital cortex, indicating that
both groups processed the spatial and contextual
information from the agoraphobia-specific stimuli.
Neural correlates of agoraphobia 2391
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Table 2. Neural activations of patients and healthy controls during the picture phase (agoraphobia-specific v. neutral pictures) sorted by lobes
and subordinated cerebral structures
Sample Lobe Cerebral structure BA HS
MNI coordinates
T p(FWE-cor)x y z
Patients Activations: agoraphobia-
specific minus neutral pictures
Frontal lobe Superior frontal gyrus 8 L −33 14 55 5.22 0.021
Frontal lobe Middle frontal gyrus 8 L −24 20 46 5.12 0.029
Frontal lobe Inferior frontal gyrus 47 R 30 17 −23 5.74 0.004
Frontal lobe Inferior frontal gyrus 47 L −48 26 −17 5.71 0.004
Frontal lobe Medial frontal gyrus 11 L 0 62 −11 5.42 0.011
Parietal lobe Precuneus 7 L −12 −82 58 8.90 <0.001
Parietal lobe Precuneus 7 R 6 −46 46 8.03 <0.001
Temporal lobe Middle temporal gyrus 20/21 L −66 −34 −17 6.43 <0.001
Temporal lobe Middle temporal gyrus 39 R 45 −79 25 12.11 <0.001
Limbic lobe Posterior cingulate 23/30 R 18 −61 13 12.83 <0.001
Limbic lobe Posterior cingulate 30 L −12 −58 7 13.26 <0.001
Limbic lobe Parahippocampal gyrus 37 R 27 −46 −11 11.97 <0.001
Occipital lobe Superior occipital gyrus 19 R 39 −85 28 11.94 <0.001
Occipital lobe Superior occipital gyrus 19 L −36 −85 31 11.07 <0.001
Occipital lobe Lingual gyrus 17 R 15 −85 −14 5.19 0.002
Occipital lobe Lingual gyrus 18 L −15 −85 −17 6.35 <0.001
Anterior lobe Culmen R 21 −37 −17 11.15 <0.001
Anterior lobe Culmen L −21 −40 −17 13.26 <0.001
Deactivations: agoraphobia-
specific minus neutral pictures
Parietal lobe Inferior parietal lobule 40 L −45 −37 43 4.99 0.044
Occipital lobe Inferior occipital gyrus 19/37 L −45 −82 −11 7.67 <0.001
Occipital lobe Middle occipital gyrus 37 R 51 −64 −11 7.48 <0.001
Occipital lobe Cuneus 18 0 −94 19 6.57 <0.001
Healthy
controls
Activations: agoraphobia-
specific minus neutral pictures
Frontal lobe Middle frontal gyrus 8 R 27 23 43 5.06 0.045
Frontal lobe Medial frontal gyrus 11 L −6 53 −17 7.34 <0.001
Parietal lobe Precuneus 7 L −15 −76 52 7.64 <0.001
Parietal lobe Superior parietal lobule 7 R 12 −73 58 7.75 <0.001
Temporal lobe Fusiform gyrus 37 L −27 −40 −17 11.69 <0.001
Temporal lobe Fusiform gyrus 37 R 30 −40 −17 10.57 <0.001
Temporal lobe Superior temporal gyrus 22 L −45 −55 16 6.15 0.001
Temporal lobe Middle temporal gyrus 21 L −63 −10 −17 6.09 0.001
Temporal lobe Inferior temporal gyrus 20 R 54 −7 −26 6.00 0.002
Limbic lobe Parahippocampal gyrus 35 R 24 −22 −26 6.36 0.001
Limbic lobe Parahippocampal gyrus 35 L −24 −22 −26 5.14 0.035
Limbic lobe Posterior cingulate 30 L −12 −61 13 11.72 <0.001
Limbic lobe Posterior cingulate 30 R 15 −58 13 11.59 <0.001
Limbic lobe Cingulate gyrus 31 R 6 −46 40 9.35 <0.001
Limbic lobe Cingulate gyrus 31 L −3 −64 28 8.03 <0.001
Occipital lobe Inferior occipital gyrus 17 L −15 −94 −14 7.42 <0.001
Occipital lobe Lingual gyrus 17 R 18 −94 −11 6.31 0.001
Occipital lobe Superior occipital gyrus 19 L −42 −85 25 11.36 <0.001
Occipital lobe Superior occipital gyrus 19 R 42 −82 25 13.96 <0.001
Deactivations: agoraphobia-
specific minus neutral pictures
Occipital lobe Inferior occipital gyrus 19/37 L −45 −76 −11 8.50 <0.001
Occipital lobe Middle occipital gyrus 19 R 48 −67 −14 7.82 <0.001
Occipital lobe Cuneus 18 L 0 −88 10 6.88 <0.001
MNI, Montreal Neurological Institute; BA, Brodmann area; HS, hemisphere; p(FWE-cor), family-wise error-corrected p<0.05;
L, left; R, right.
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However, contrary to our initial hypothesis, we could
not detect any group differences in areas of the classi-
cal fear network (including the amygdala) in response
to agoraphobia-related stimuli. On the behavioural
level, agoraphobia-specific pictures were rated to be
more anxiety-inducing than neutral pictures by
patients compared with healthy controls, and these
ratings were correlated with clinical scores and the
magnitude of the clinical impairment. Therefore, the
pictures were likely to be differently perceived depend-
ing on group status (patients v. controls). The failure
to detect activation differences on the neuronal level
during the perception phase might be related to lim-
ited realization of stimulus presentations specific for
the individual anxiety-inducing situation of each indi-
vidual patient.
This result may support the idea that the amygdala
is a switch point in the neural fear network during
the evaluation of threats in the environment, which
(dependent on the strength of its anxiety-inducing
content) is not necessarily activated more strongly in
patients (compared with healthy controls) when con-
trasting pictures of various agoraphobia-specific situa-
tions with neutral pictures. The role of the amygdala as
a pivotal structure within the distributed fear network,
but not necessarily as the single indicator of an anxious
reaction, is in line with Gorman et al. (2000). This the-
ory postulates that reciprocal connections of the amyg-
dala disseminate information for the coordination of
autonomic and behavioural response by connections
to regions participating in processing and evaluation
of sensory information, e.g. the sensory thalamus and
insula. From this holistic perspective, the amygdala is
an important structure for the perception processes
of anxiety-related stimuli, such as the evaluation of rel-
evance, valence and salience, but it has not to be clas-
sified as a more significant part of the fear network
than other regions (Holzschneider & Mulert, 2011;
Dresler et al. 2012).
Our results have to be interpreted within the context
of a range of limitations. We are unable to separate the
activation patterns in patients suffering from panic dis-
order with agoraphobia from comparable findings in
patients suffering from other mental disorders, such
as, for instance, specific phobias (Etkin & Wager,
2007), social anxiety disorder (Lorberbaum et al. 2004;
Guyer et al. 2008) or panic disorder without agora-
phobia. A comparison of the neural response patterns
of these patient groups would be worth pursuing in
future research. Moreover, the realization of this large
data sample was only possible using several tomo-
graphs, which may have caused unwanted variance.
We controlled this by calculating a joint multicentre
quality control (Kircher et al. 2013) as a criterion for
data inclusion, and we controlled for variance of each
study site in each analysis. However, we did not find
significant differences between study sites. Further-
more, we could not control to what extent participants
were able to perceive presented stimuli as real. There-
fore induction of emotion and neural activity may
differ between subjects. The use of the word ‘panic’
as the anticipatory cue in our paradigm might have
had an effect per se on increasing arousal, especially
in the patient group. Although this might have contrib-
uted to the anticipatory effect, the observed correlation
between the striatal activation during anticipation
and the subjective anxiety ratings of the agoraphobic
pictures indicates that anticipatory activation was re-
lated to the anticipated agoraphobic pictures that
were rated as more anxiety-inducing by patients com-
pared with healthy controls. Finally the MRI device
itself might be an anxiety-inducing situation –
especially for patients who suffer from panic disorder –
which may affect the neural activity (e.g. baseline acti-
vation due to anxious arousal induced by being in
this situation) or result in a sample bias despite
sample characteristics being comparable with the over-
arching treatment study (Gloster et al. 2011)
(HAMAfMRI-sample: mean=23.1, S.D. =6.3; MIfMRI-sample:
mean=2.8, S.D. =0.8 v. HAMAtreatment-sample: mean=
24.1, S.D.=5.2; MItreatment-sample: mean=3.0, S.D.=0.9).
In summary, our study provides evidence for differ-
ent neural processing in patients with panic disorder
with agoraphobia with regard to anticipation in com-
parison with the perception of agoraphobia-related
stimuli in the VS and insula. This finding may indicate
a neural correlate for anticipatory anxiety, which is
often reported as a more impairing burden for patients
than the fear itself experienced in agoraphobic situa-
tions, and might go hand in hand with a heightened at-
tention to internal panic-associated body symptoms
and an intensified evaluation of the environment for
aversive conditions.
From a therapeutical perspective, we know that
both frequency and duration of in vivo exposure in-
crease when a therapist accompanies and supports
the patient during confrontation with agoraphobic
situations. In other words, overcoming anticipatory
anxiety may be the most difficult first step in treat-
ment, ensuring that the patient profits from the most
relevant feature of his or her treatment regimen: the ex-
posure to agoraphobic situations (Gloster et al. 2011).
The investigation of neural plasticity in brain struc-
tures sensitive to, for example, such psychotherapeu-
tical treatments or new approaches like repetitive
transcranial magnetic stimulation (Zwanzger et al.
2009) will be the focus of future studies and might im-
prove the therapeutical conditions for patients suffer-
ing from panic disorder with agoraphobia and other
anxiety disorders.
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